Drug developer Cytori Therapeutics Inc., after incurring losses, has paid off debt with the help of a new $17.7 million loan.

San Diego-based Cytori is developing several therapies, including a potential treatment for impaired hand function caused by the rare autoimmune disease scleroderma. The company is also in trials for potential treatments for osteoarthritis, burns and cardiovascular disease.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.